Europe, Global Sentinel

Hancock seizes on new data to counter EU doubts on Oxford jab

Study shows single dose of Pfizer or AstraZeneca vaccine cuts risk of serious illness by more than 80%

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The Oxford/AstraZeneca coronavirus vaccine is slightly more effective than that of Pfizer/BioNTech on some measures, the health secretary has said as he seized on new data and argued it should prompt other countries to re-evaluate their approach.

Pfizer/BioNTech